Everything You Need to Know About TCA cycle for Step 1

The TCA (tricarboxylic acid) cycle is one of those Step 1 topics that feels “basic” until you realize it connects everything: glycolysis, beta-oxidation, amino acid metabolism, oxidative phosphorylation, and multiple vitamin deficiencies. If you can confidently track where the carbon goes, where the electrons go, and what shuts the cycle down, you’ll pick up points across biochem and clinically oriented vignettes.

---

Big-Picture Definition (and Why Step 1 Loves It)

The TCA cycle (Krebs/citric acid cycle) is a mitochondrial pathway that:

• Oxidizes acetyl-CoA to CO₂
• Captures high-energy electrons as NADH and FADH₂
• Produces GTP (substrate-level phosphorylation)
• Provides intermediates for biosynthesis (amphibolic pathway)

Location: Mitochondrial matrix (note: succinate dehydrogenase is embedded in the inner mitochondrial membrane as Complex II of the ETC).

Core concept: The TCA cycle itself does not make much ATP directly. It makes NADH/FADH₂, and those drive ATP production via the ETC.

---

The Cycle in One Table (Know This Cold)

Mnemonic (order): Citrate Is Krebs’ Starting Substrate For Making Oxaloacetate
Citrate → Isocitrate → α-Ketoglutarate → Succinyl-CoA → Succinate → Fumarate → Malate → Oxaloacetate

---

Yield and ATP Accounting (Don’t Overcomplicate It)

Per one acetyl-CoA, the TCA cycle produces:

• 3 NADH
• 1 FADH₂
• 1 GTP
• 2 CO₂

Using typical Step 1 P/O ratios:

• NADH ≈ 2.5 ATP
• FADH₂ ≈ 1.5 ATP
• GTP ≈ 1 ATP

So:
$3(2.5) + 1(1.5) + 1 = 7.5 + 1.5 + 1 = 10\ \text{ATP per acetyl-CoA}$

Per one glucose (2 acetyl-CoA enter TCA): ~20 ATP from TCA alone.

HY pitfall: If the ETC is inhibited, TCA slows down because NAD⁺ and FAD are not regenerated efficiently (NADH builds up → dehydrogenases get inhibited).

---

Regulation: What Speeds It Up vs Slams the Brakes?

Rate-limiting enzyme: Isocitrate dehydrogenase

Activated by:

• ADP
• Ca²⁺ (especially in contracting muscle)

Inhibited by:

• ATP
• NADH

Other key control points

• Citrate synthase: inhibited by citrate, succinyl-CoA, NADH, ATP
• α-KG dehydrogenase: inhibited by succinyl-CoA, NADH; activated by Ca²⁺

Clinical tie-in: In hypoxia/ETC blockade → NADH accumulates → TCA dehydrogenases inhibited → acetyl-CoA can be diverted (e.g., ketogenesis in liver under certain contexts).

---

Vitamins & Cofactors: The “Step 1 Multiplier”

The PDH/α-KG dehydrogenase cofactor set (same theme)

Both pyruvate dehydrogenase and α-ketoglutarate dehydrogenase require:

• TPP (B1, thiamine)
• Lipoic acid
• FAD (B2, riboflavin)
• NAD⁺ (B3, niacin)
• CoA (B5, pantothenic acid)

Classic mnemonic: Tender Loving Care For Nancy (TPP, Lipoate, CoA, FAD, NAD)

HY clinical correlations:

• Thiamine (B1) deficiency → impaired PDH and α-KG DH → ↓ ATP production (esp. brain)
  • Think Wernicke-Korsakoff (confusion, ophthalmoplegia, ataxia; memory issues/confabulation) and beriberi
• Niacin (B3) deficiency → ↓ NAD⁺/NADP⁺ → energy issues + pellagra (dermatitis, diarrhea, dementia)

---

Pathophysiology: What Happens When the TCA Cycle Can’t Run?

The TCA cycle “fails” most commonly because:

1. Not enough oxygen / ETC impaired → NADH can’t be oxidized back to NAD⁺
2. Key enzymes inhibited (toxins)
3. Cofactor deficiencies (B vitamins)
4. Mitochondrial disease (less common but testable)

When TCA slows:

• ↓ NADH/FADH₂ delivery to ETC → ↓ ATP
• Cells compensate with anaerobic glycolysis → lactic acidosis
• Tissues most affected: CNS and heart (high oxidative metabolism)

---

High-Yield Inhibitors & Toxins (Vignette Favorites)

Fluoroacetate (via aconitase inhibition)

• Mechanism: Fluoroacetate → fluorocitrate → inhibits aconitase (citrate → isocitrate step)
• Result: TCA stalls early, energy failure
• Presentation: severe toxicity (GI/CNS/cardiac), can be fatal

Arsenic

• Mechanism: binds lipoic acid → inhibits:
  • Pyruvate dehydrogenase
  • α-Ketoglutarate dehydrogenase
• Result: ↓ acetyl-CoA entry and ↓ TCA flux → ↓ ATP, ↑ pyruvate → ↑ lactate
• Presentation: GI upset, hypotension/shock, “garlic” breath classically cited; peripheral neuropathy can occur
• Treatment: Dimercaprol (British anti-Lewisite) or succimer (chelation)

Malonate (competitive inhibitor)

• Mechanism: Competitive inhibitor of succinate dehydrogenase (Complex II)
• Clue: structurally resembles succinate
• Result: ↓ fumarate formation; impaired Complex II electron transfer

Cyanide / CO

Not TCA inhibitors directly, but ETC poisons that secondarily shut down TCA by backing up NADH.

• Cyanide inhibits Complex IV (cytochrome c oxidase) → severe hypoxia at cellular level
• CO binds heme iron (incl. cytochromes) and Hb → impaired O₂ delivery/utilization

---

“Clinical Presentation” Patterns You Should Recognize

Because TCA impairment is usually a mitochondrial energy failure story, symptoms often look like:

• Neuro: confusion, seizures, ataxia, neuropathy
• Cardiac: cardiomyopathy, arrhythmias (energy-starved myocardium)
• Systemic: fatigue, weakness
• Labs: elevated lactate (if shunting to anaerobic glycolysis), metabolic acidosis

High-yield association: giving glucose to a thiamine-deficient patient can worsen lactic acidosis.

• Why: glycolysis produces pyruvate, but PDH can’t process it efficiently → pyruvate → lactate
• Clinical tie: In alcohol use disorder or malnourished patients, give thiamine before glucose.

---

Diagnosis (How Questions Actually Ask It)

You won’t usually “diagnose TCA cycle failure” directly; instead you infer it from:

• Metabolic acidosis with elevated lactate
• Exposure history (arsenic, fluoroacetate)
• Signs of thiamine deficiency
• Mitochondrial disease clues (multi-system, maternal inheritance, high lactate)

Common vignette “tells”

• Alcohol use disorder + confusion/ataxia → thiamine deficiency affecting PDH/α-KG DH
• Poison ingestion + sudden collapse → consider mitochondrial poisons
• Competitive inhibitor question + “looks like substrate” → malonate vs succinate

---

Treatment Principles (What Step 1/2 Expect)

Treatment depends on cause, but the logic is consistent:

• Cofactor deficiency: replete the vitamin
  • Thiamine for suspected B1 deficiency
  • Consider nutrition support broadly
• Chelation for metals:
  • Dimercaprol or succimer for arsenic
• Support oxidative metabolism: oxygenation/ventilation, hemodynamics
• Stop the exposure (remove toxin source)

Step 2 flavor: manage complications (acidosis, seizures, shock), but Step 1 mostly focuses on the biochemical target and the antidote (if any).

---

Amphibolic Connections (TCA as a “Metabolic Roundabout”)

The TCA cycle is central because its intermediates are pulled off for synthesis:

Anaplerotic reactions (refilling the cycle)

Most tested:

• Pyruvate carboxylase (biotin, ATP)
  Pyruvate → oxaloacetate
  • Activated by acetyl-CoA
  • Important for gluconeogenesis and maintaining TCA capacity

If oxaloacetate is depleted (e.g., pulled to gluconeogenesis), acetyl-CoA can’t effectively enter TCA → contributes to ketogenesis (classic fasting/diabetes physiology connection).

---

High-Yield First Aid Cross-References (Where to Anchor This)

In First Aid for the USMLE Step 1 (Biochemistry), the TCA cycle content is typically integrated across:

• Carbohydrate metabolism: TCA steps, yield, regulation
• Pyruvate dehydrogenase complex: shared cofactors with α-KG DH; thiamine/arsenic associations
• ETC/oxidative phosphorylation: how ETC blockade backs up NADH and slows TCA
• Vitamins: B1, B2, B3, B5 and their roles in energy metabolism
• Enzyme inhibition: malonate, fluoroacetate, arsenic

Use FA as your “map,” but make sure you can answer:

• Which step makes GTP? (succinyl-CoA synthetase)
• Which step is Complex II? (succinate dehydrogenase)
• Which steps release CO₂? (isocitrate DH, α-KG DH)
• Which step is rate-limiting? (isocitrate DH)
• Which enzymes need the 5 cofactors? (PDH, α-KG DH)

---

Rapid-Fire HY Facts (Exam-Day Ready)

• TCA is aerobic indirectly: it depends on the ETC to regenerate NAD⁺/FAD.
• Succinate dehydrogenase = Complex II (inner mitochondrial membrane).
• Net per acetyl-CoA: 3 NADH, 1 FADH₂, 1 GTP, 2 CO₂ ≈ 10 ATP.
• Rate-limiting: isocitrate dehydrogenase (↑ ADP, Ca²⁺; ↓ ATP, NADH).
• Arsenic inhibits lipoic acid → inhibits PDH + α-KG DH → lactic acidosis.
• Malonate competitively inhibits succinate dehydrogenase.
• Fluoroacetate inhibits aconitase.
• Thiamine deficiency hits oxidative tissues hard → neurologic findings + lactic acidosis risk (give thiamine before glucose).